RNA EPS Estimates
Atrium Therapeutics, Inc.
$7.76
+$0.08(+0.98%)
20
Overall
--
Value
27
Tech
13
Quality
Market Cap
$131.37M
Volume
60.22K
52W Range
$7.63 - $16.77
Target Price
$25.00
RNA EPS estimates: the consensus estimate for Atrium Therapeutics, Inc.'s current fiscal year is -$5.08 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
RNA EPS Estimates
- EPS estimate, current quarter
- $-1.70
- EPS estimate, next quarter
- $-1.76
- EPS estimate, current year
- $-5.08
- EPS estimate, next year
- $-8.11
- EPS growth, 3-year
- -32.37%
| Fiscal year | EPS |
|---|---|
| 2022 | $-3.34 |
| 2021 | $-2.85 |
| 2020 | $-2.05 |
| 2019 | $-1.44 |
| 2018 | $-0.54 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RNA | $7.76 | +1.0% | 60.22K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Atrium Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW